Translational Medicine Operations Hub

Medicine & Life Sciences

1. Luxembourg 100%
2. Proteomics 66%
3. Parkinson Disease 52%
4. Biomarkers 48%
5. Proteins 47%
6. Peptides 33%
7. Mass Spectrometry 33%
8. Neoplasms 31%
9. Genes 28%
10. Population 26%
11. Glioblastoma 25%
12. Therapeutics 25%
13. MicroRNAs 25%
14. Pharmaceutical Preparations 23%
15. Quality Control 23%
16. Myocardial Infarction 22%
17. artesunate drug combination amodiaquine 21%
18. Clinical Trials 20%
19. Datasets 20%
20. Meta-Analysis 20%
21. RNA 19%
22. Gene Expression 19%
23. Workflow 18%
24. Health Surveys 18%
25. Randomized Controlled Trials 17%
26. Health 17%
27. Data Analysis 17%
28. Temperature 17%
29. Systematic Reviews 16%
30. Senegal 15%
31. Metabolomics 15%
32. Precision Medicine 15%
33. Paraffin 15%
34. Malaria 14%
35. Network Meta-Analysis 14%
36. Gene Regulatory Networks 14%
37. Gastrointestinal Microbiome 14%
38. Formaldehyde 14%
39. Antimalarials 14%
40. DNA 14%
41. Proteome 13%
42. Lung Neoplasms 13%
43. Guidelines 13%
44. Protein Interaction Maps 13%
45. Phenotype 12%
46. HIV-1 12%
47. Drug Development 12%
48. Adiposity 12%
49. Alzheimer Disease 12%
50. Endothelial Progenitor Cells 12%
51. Centrifugation 12%
52. Safety 12%
53. plastin 12%
54. Heart Failure 12%
55. Urine 11%
56. Praziquantel 11%
57. Machine Learning 11%
58. Melanoma 11%
59. Blood Cells 10%
60. Data Accuracy 10%
61. Microbiota 10%
62. Stem Cells 10%
63. Breast Neoplasms 10%
64. Ubiquitin 10%
65. Serum 10%
66. Organoids 10%
67. Technology 10%
68. Ions 10%
69. In Vitro Techniques 10%
70. Multimorbidity 10%
71. B-Cell Chronic Lymphocytic Leukemia 9%
72. Random Allocation 9%
73. Cytokines 9%
74. Plasmodium falciparum 9%
75. Artificial Intelligence 9%
76. Schistosomiasis 9%
77. Databases 9%
78. Computational Biology 9%
79. Gene Ontology 9%
80. Out-of-Hospital Cardiac Arrest 9%
81. Research Personnel 9%
82. Education 9%
83. Acute Myeloid Leukemia 9%
84. Actins 9%
85. Inflammation 9%
86. Arteriosclerosis 9%
87. Natural Killer Cells 8%
88. Mutation 8%
89. dihydroartemisinin 8%
90. Transcription Factors 8%
91. Frailty 8%
92. Registries 8%
93. Long Noncoding RNA 8%
94. Sleep 8%
95. RNA Sequence Analysis 8%
96. Actin Cytoskeleton 8%
97. Growth 8%
98. Exercise 8%
99. Brain 8%
100. Hypoxia 8%